**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 24437-41-0 |1-Methyl-2-Pyrroleacetonitrile | 95% | 246-248-5 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 22 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. Irritating to eyes, respiratory system and
skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
May be metabolized to cyanide which in turn acts by inhibiting
cytochrome oxidase impairing cellular respiration.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause cardiac disturbances. May be harmful if
swallowed. May cause central nervous system depression. Metabolism
may release cyanide, which may result in headache, dizziness,
weakness, collapse, unconsciousness and possible death.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled. May
cause cardiac abnormalities. Can produce delayed pulmonary edema.
May be metabolized to cyanide which in turns act by inhibiting
cytochrome oxidase impairing cellular respiration. Inhalation may
result in symptoms similar to cyanide poisoning which include
tachypnea, hyperpnea (abnormally rapid or deep breathing), and
dyspnea (labored breathing) followed rapidly by respiratory
depression. Pulmonary edema may occur. Inhalation at high
concentrations may cause CNS depression and asphixiation.
Chronic:
May be metabolized to cyanide which in turn acts by inhibiting
cytochrome oxidase impairing cellular respiration. Effects may be
delayed. Chronic exposure to cyanide solutions may lead to the
development of a "cyanide" rash, characterized by itching, and by
macular, papular, and vesicular eruptions, and may be accompanied by
secondary infections.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing
is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
Treat symptomatically and supportively. May be partially metabolized
to cyanide in the body.
Antidote:
Always have a cyanide antidote kit on hand when working with cyanide
compounds. Get medical advice to use.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Vapors may
be heavier than air. They can spread along the ground and collect
in low or confined areas. Runoff from fire control or dilution water
may cause pollution.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Use water spray,
dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Provide
ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation. Use with adequate ventilation. Wash clothing before
reuse.
Storage:
Store in a tightly closed container. Store in a dry area. Keep
refrigerated. (Store below 4C/39F.)
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 24437-41-0:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: yellow to light brown
Odor: Not available.
pH: 7 @ 25 g/l aq.sol.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 131 deg C @ 24.00mb
Freezing/Melting Point: 20 deg C
Autoignition Temperature: 495 deg C ( 923.00 deg F)
Flash Point: > 109 deg C (> 228.20 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: 25 g/l water (20C)
Specific Gravity/Density: 1.0360g/cm3
Molecular Formula: C7H8N2
Molecular Weight: 120.15
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 24437-41-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-Methyl-2-Pyrroleacetonitrile -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
IMO
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
RID/ADR
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 24437-41-0: No information available.
Canada
CAS# 24437-41-0 is listed on Canada's NDSL List.
CAS# 24437-41-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 24437-41-0 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #3 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
1-(Pyrrolidinocarbonylmethyl)piperazine, 95+%
| 39890-45-4 |
|
Procion blue HB
| 12236-82-7 |
|
Cyclopentadienyliron Dicarbonyl Dimer, 99%
| 38117-54-3 |
|
Bis(6-carboxypentyl-2,4,5-trichlorophenyl) oxalate
| 75203-51-9 |
|
Benzenesulfonamide, 97% (titr.)
| 98-10-2 |
|
(s)-(+)-Methyl mandelate, 98+%
| 21210-43-5 |
|
1-Monobutyrin (Pract)
| 557-25-5 |
|
1,5-Dibromo-3-Methylpentane, 98%
| 4457-72-1 |
|
(s)-(+)-2-Methylbutyric acid 98%
| 1730-91-2 |
|
6-Nitropiperonal, 98+%
| 712-97-0 |
|
Allyl Bromide, Stabilized with Ca. 300 ppm Propylene Oxide, 99%
| 106-95-6 |
|
6-Chloropurine, 99+%
| 87-42-3 |
|
1,4-Butanedithiol, 94%
| 1191-08-8 |
|
All-Trans-Retinal, 99% (UV-VIS)
| 0-00-1 |
|
1,1,4,7,7-Pentamethyldiethylenetriamine, 99+% (GC)
| 3030-47-5 |
|
Ethyl 3-(methylthio)propionate, 99+%
| 13327-56-5 |
|
1,1,1-Trifluoroacetone, 98+%
| 421-50-1 |
|
Acrylamide-bis premix 37.5:1 (2.6% concentration)
| 79-06-1 |
|
Aniline-2,3,4,5,6-d5, 99+ atom% D
| 4165-61-1 |
|
4-Fluorophenyl sulfone, 99%
| 383-29-9 |
|
1,2-Dibromoethylene, 98%, mixture of cis and trans
| 540-49-8 |
|
1-Methyl-2-formylbenzimidazole, 99+%
| 3012-80-4 |
|
4-Aminobenzo-15-Crown-5, Hydrochloride, 98%
| 0-00-1 |
|
2-Methylthio-2-imidazoline hydriodide, 99%
| 5464-11-9 |
|
Ethyl 2-bromoisobutyrate, 98%
| 600-00-0 |
|
Sarcosine, 98%
| 107-97-1 |
|
Phenyl vinyl sulfide, 97%
| 1822-73-7 |
|
5-Hydroxy-2-methyl-3-trifluoromethyl-1H-pyrazole, 99+%
| 0-01-1 |
|
3-Chloropyridine, 99%
| 626-60-8 |
|
2-Chloro-3-ethylbenzoxazolium tetrafluoro- borate, 97%
| 63175-96-2 |
|
1-Naphtaldehyde, 99% (gc)
| 66-77-3 |
|
2-Chloromercuri-4-nitrophenol
| 24579-90-6 |
|
Ethylenediamine Tetraacetic Acid, Dipotassium Salt Dihydrate
| 2001-94-7 |
|
Hydroxybutyl methyl cellulose
| 9041-56-9 |
|
1-Methyl-2-Pyrroleacetonitrile, 95%
| 24437-41-0 |
|
DL-Alanyl-DL-alanine
| 2867-20-1 |
|
1,8-Naphthalic anhydride, 97%
| 81-84-5 |
|
2-Iodo-1,1,1-trifluoroethane, 99%
| 353-83-3 |
|
Tetrapentylammonium Bromide, 99+%
| 866-97-7 |
|
4-Chromanone, 96%(GC)
| 491-37-2 |
|
1,2-Dimethoxy-4-(2-Propenyl)Benzene, 98%
| 93-15-2 |
|
Boc-Sarcosine, 99+%
| 13734-36-6 |
|
[Bis(trimethylsilyl)]sulfide, 98%
| 3385-94-2 |
|
Bicyclo(3.3.1)Nonan-9-One, 99%
| 17931-55-4 |
|
4-Bromo-o-xylene, tech. 75-80% (remainder 3-bromo-o-xylene)
| 576-23-8 |
|
4,4'-Oxydiphenol, 99%
| 1965-09-9 |
|
Anthranilonitrile, 98%
| 1885-29-6 |
|
Fmoc-L-Proline, 99%
| 71989-31-6 |
|
L-(+)-2-Amino-6-Phosphonohexanoic Acid 98% e.e.
| 0-00-1 |
|
DL-2-Aminobutyric Acid, 99+%
| 2835-81-6 |
|
|